Erbitux 100mg Infusion
Marketer
Merck Ltd
Salt Composition
Cetuximab (100mg)
Overview Erbitux 100mg Infusion
Cetuximab 100mg infusion is indicated for treating head and neck and colorectal cancers. It targets cancer cells, facilitating their destruction by the patient's immune system. Administered intravenously under medical supervision, the dosage and frequency are determined individually by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial, as incorrect usage or overdose can lead to severe adverse reactions. Discontinue use only as directed by your physician. Frequently reported side effects include nausea, headache, vomiting, and skin rash; promptly report any concerning symptoms to your doctor, as management strategies exist. Seek immediate medical attention if you experience sudden respiratory distress, fever, or chills. Regular blood tests monitor blood counts, cardiac and hepatic function, and electrolyte balance. Increased sun sensitivity necessitates protective measures outdoors. Prior to treatment, disclose any pre-existing heart or kidney conditions, and all medications, including those for infections, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout treatment.
Primary Ingredients of Erbitux 100mg Infusion
No information provided. Please provide the text you wish me to rephrase.
Uses of Erbitux 100mg Infusion
Cancers affecting the head and neck, and colorectal cancer
Major Benefits of Erbitux 100mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Erbitux 100mg Infusion:
- Nausea
- Headache
- Vomiting
- Conjunctivitis
- Skin rash
- Diarrhea
- Infusion reaction
- Decreased magnesium level in blood
- Increased liver enzymes
How to use Erbitux 100mg Infusion:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Erbitux 100mg Infusion works:
Cetuximab (Erbitux) 100mg, administered intravenously, is a targeted therapy. This monoclonal antibody attaches to specific receptors found on cancerous cells, marking them for elimination by the patient's own immune defenses.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Erbitux 100mg infusion may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Cetuximab 100mg infusion carries a potential risk during pregnancy. While human data is scarce, animal research indicates adverse effects on fetal development. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The administration of Erbitux 100mg via infusion is likely incompatible with breastfeeding. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Cetuximab 100mg infusion may impair driving ability due to potential adverse effects.
KidneySAFE IF PRESCRIBED
Cetuximab 100mg infusion is likely safe for individuals with impaired renal function. Preliminary findings indicate dose modification may be unnecessary in this population. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data on the administration of 100mg Erbitux infusions to patients with hepatic impairment is scarce. Seek medical advice.
What if you forget to take Erbitux 100mg Infusion :
Omit a scheduled Erbitux 100mg infusion? Seek your physician's advice.
Facts to Know About Erbitux 100mg Infusion
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Monoclonal antibody EGFR (ErbB1/HER1) inhibitors |
3,018 People bought this recently